Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -620.83%-15.22M | ---- | 111.08%2.92M | ---- | 56.37%-26.37M | ---- | -75.63%-60.45M | ---- | -87.62%-34.42M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 60.00%-4K | ---- | -42.86%-10K | ---- | 95.10%-7K | ---- | 22.28%-143K | ---- | 8.46%-184K |
| Impairment and provisions: | ---- | 1,995.15%9.93M | ---- | -98.24%474K | ---- | 67.85%26.96M | ---- | 176.14%16.06M | ---- | 28.58%5.82M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.57M |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | -26.72%3.79M | ---- | 67.02%5.18M | ---- | --3.1M |
| -Impairment of goodwill | ---- | --5.71M | ---- | ---- | ---- | --34.23M | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | 789.87%4.22M | ---- | 104.29%474K | ---- | -201.58%-11.06M | ---- | 7,062.50%10.89M | ---- | -96.64%152K |
| Revaluation surplus: | ---- | -111.31%-322K | ---- | 2,341.73%2.85M | ---- | ---127K | ---- | ---- | ---- | ---- |
| -Other fair value changes | ---- | -111.31%-322K | ---- | 2,341.73%2.85M | ---- | ---127K | ---- | ---- | ---- | ---- |
| Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -100.00%-134K | ---- | 98.29%-67K |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 92.40%-49K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -644.44%-134K | ---- | 99.45%-18K |
| Depreciation and amortization: | ---- | --299K | ---- | ---- | ---- | 69.47%322K | ---- | -90.90%190K | ---- | -36.87%2.09M |
| -Amortization of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -61.11%611K |
| Financial expense | ---- | -81.47%48K | ---- | -55.03%259K | ---- | 52.38%576K | ---- | -81.13%378K | ---- | -54.94%2M |
| Special items | ---- | ---- | ---- | -84.55%138K | ---- | --893K | ---- | ---- | ---- | ---- |
| Operating profit before the change of operating capital | ---- | -179.51%-5.27M | ---- | 195.50%6.63M | ---- | 105.09%2.24M | ---- | -78.07%-44.09M | ---- | -333.87%-24.76M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -109.92%-94K | ---- | -92.54%948K | ---- | 2,841.90%12.71M | ---- | 129.96%432K | ---- | -111.62%-1.44M |
| Accounts receivable (increase)decrease | ---- | -45.95%-12.95M | ---- | -126.36%-8.87M | ---- | 201.11%33.66M | ---- | -80.57%11.18M | ---- | 996.88%57.54M |
| Accounts payable increase (decrease) | ---- | 306.14%14.07M | ---- | 84.56%-6.82M | ---- | -223.45%-44.19M | ---- | 284.45%35.79M | ---- | -1,038.85%-19.41M |
| Financial assets at fair value (increase)decrease | ---- | -100.55%-734K | ---- | ---366K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from business operations | ---- | 41.26%-4.98M | ---- | -291.75%-8.48M | ---- | 33.59%4.42M | ---- | -72.24%3.31M | ---- | 939.86%11.93M |
| Other taxs | ---- | ---- | ---- | ---- | ---- | ---74K | ---- | ---- | ---- | 122.75%873K |
| Special items of business | 18.29%-5.73M | ---- | -427.39%-7.01M | ---- | 80.21%-1.33M | ---- | -190.16%-6.71M | ---- | 121.54%7.45M | ---- |
| Net cash from operations | 18.29%-5.73M | 41.26%-4.98M | -427.39%-7.01M | -295.01%-8.48M | 80.21%-1.33M | 31.35%4.35M | -190.16%-6.71M | -74.13%3.31M | 121.54%7.45M | 343.47%12.8M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -60.00%4K | ---- | 42.86%10K | ---- | -95.10%7K | ---- | -22.28%143K | ---- | 37.31%184K |
| Loan receivable (increase) decrease | ---- | ---- | ---- | --82K | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 168.00%134K | ---- | -98.63%50K |
| Purchase of fixed assets | ---- | ---- | ---- | ---- | ---- | 79.59%-20K | ---- | 94.37%-98K | ---- | -186.99%-1.74M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 86.25%-399K |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | --88K | ---- | ---- | ---- | ---- |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 59.26%-2.2M | ---- | ---5.4M |
| Other items in the investment business | ---- | ---- | ---- | ---- | 1,383.33%89K | ---- | -88.68%6K | ---- | 103.93%53K | ---- |
| Net cash from investment operations | ---- | -95.65%4K | ---- | 22.67%92K | 1,383.33%89K | 103.71%75K | -88.68%6K | 72.34%-2.02M | 103.93%53K | -174.77%-7.31M |
| Net cash before financing | 18.29%-5.73M | 40.66%-4.98M | -465.24%-7.01M | -289.62%-8.39M | 81.51%-1.24M | 242.95%4.42M | -189.44%-6.71M | -76.51%1.29M | 120.88%7.5M | 21.61%5.49M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | ---- | ---- | ---- | -85.23%1.81M | ---- | -91.29%12.26M | ---- | -39.76%140.83M |
| Refund | ---- | 60.98%-1.3M | ---- | -458.75%-3.32M | ---- | 97.01%-594K | ---- | 88.82%-19.85M | ---- | 24.13%-177.54M |
| Issuing shares | ---- | -33.09%5.86M | ---- | 534.78%8.76M | ---- | --1.38M | ---- | ---- | ---- | ---- |
| Interest paid - financing | ---- | 90.41%-28K | ---- | 49.31%-292K | ---- | -52.38%-576K | ---- | 88.29%-378K | ---- | 17.70%-3.23M |
| Other items of the financing business | -44.58%3.2M | ---- | 4,374.07%5.77M | ---- | 71.46%-135K | ---- | 95.11%-473K | 1,686.30%1.16M | -189.76%-9.68M | -269.77%-73K |
| Net cash from financing operations | -44.58%3.2M | -12.06%4.23M | 4,374.07%5.77M | 207.22%4.81M | 71.46%-135K | 121.84%1.57M | 95.11%-473K | 82.19%-7.17M | -189.76%-9.68M | -338.65%-40.23M |
| Effect of rate | ---- | ---- | ---- | ---- | -305.11%-2.01M | -374.22%-5.51M | 86.64%978K | 869.73%2.01M | --524K | -131.83%-261K |
| Net Cash | -104.12%-2.53M | 79.06%-750K | 9.89%-1.24M | -159.79%-3.58M | 80.85%-1.38M | 201.94%5.99M | -230.01%-7.18M | 83.09%-5.88M | 91.35%-2.18M | -262.53%-34.74M |
| Begining period cash | -15.47%4.1M | -42.48%4.85M | -42.48%4.85M | 6.04%8.43M | 6.04%8.43M | -32.72%7.95M | -38.73%7.95M | -74.76%11.82M | -72.91%12.97M | 90.14%46.81M |
| Cash at the end | -56.53%1.57M | -15.47%4.1M | -28.51%3.61M | -42.48%4.85M | 189.12%5.05M | 6.04%8.43M | -84.58%1.75M | -32.72%7.95M | -50.24%11.32M | -74.76%11.82M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Fan Chen Certified Public Accountants Co., Ltd. | -- | Fan Chen Certified Public Accountants Co., Ltd. | -- | Fan Chen Certified Public Accountants Co., Ltd. | -- | Fan Chen Certified Public Accountants Co., Ltd. | -- | Kaiyuan Shun Tak Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.